Skip to Content

Delaware Ivy Value A IYVAX

Medalist Rating as of | See Macquarie Investment Hub
  • NAV / 1-Day Return 17.18  /  +0.47 %
  • Total Assets 458.3 Mil
  • Adj. Expense Ratio
    1.080%
  • Expense Ratio 1.080%
  • Distribution Fee Level Above Average
  • Share Class Type Front Load
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 1.28%
  • Turnover 103%

USD | NAV as of Apr 23, 2024 | 1-Day Return as of Apr 23, 2024, 10:14 PM GMT+0

Morningstar’s Analysis IYVAX

Will IYVAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in Delaware Ivy Value A's People and Process Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings IYVAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 31.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Dover Corp

3.25 15.8 Mil
Industrials

CVS Health Corp

3.14 15.2 Mil
Healthcare

American International Group Inc

3.14 15.2 Mil
Financial Services

Lowe's Companies Inc

3.13 15.2 Mil
Consumer Cyclical

Johnson & Johnson

3.13 15.2 Mil
Healthcare

The Walt Disney Co

3.13 15.2 Mil
Communication Services

Exxon Mobil Corp

3.13 15.1 Mil
Energy

Fidelity National Information Services Inc

3.12 15.1 Mil
Technology

Motorola Solutions Inc

3.11 15.0 Mil
Technology

Oracle Corp

3.10 15.0 Mil
Technology